Significant clinical & MRI improvements shown with PLEGRIDY

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Significant clinical & MRI improvements shown with PLEGRIDY

Postby MSUK » Tue Oct 01, 2013 2:10 am

Significant clinical and MRI improvements shown with PLEGRIDY(TM) (Peginterferon Beta-1a)

Biogen Idec announced new data analyses from year one of the two-year, pivotal, Phase 3 ADVANCE study of PLEGRIDY(TM) (peginterferon beta-1a). PLEGRIDY is an investigational subcutaneous injectable for relapsing forms of multiple sclerosis (RMS), in which interferon beta-1a is pegylated to prolong the molecule's exposure in the body and enable the study of a less frequent dosing schedule. Clinical and MRI data from the study demonstrated a reduction in relapses, disability progression and the number of MS lesions when compared to placebo, and further support the clinical efficacy profile of PLEGRIDY. These data will be presented this week at the 29(th) Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark 2-5 October....... Read More - http://www.ms-uk.org/PEGylatedinterferonbeta
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2142
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service